Lv61
2146 积分 2025-03-13 加入
A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers
3小时前
待确认
Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis
3小时前
待确认
犬骨关节炎的发病机制及诊疗研究进展
2个月前
已完结
犬源抗PD-L1单克隆抗体的筛选、表达及鉴定
2个月前
已完结
犬细小病毒治疗性单克隆抗体的研发
2个月前
已完结
犬IL-31稳转细胞腺的构建、单克隆抗体的制备及ELISA方法的建立
2个月前
已完结
Long term use of lokivetmab (Cytopoint®) in atopic dogs
3个月前
已完结
[Chinese expert consensus on the use of Omalizumab in allergic asthma (2021 version)]
6个月前
已完结
[Chinese guidelines for the diagnosis and treatment of allergic asthma (the second edition, 2025)]
6个月前
已完结
皖公网安备34019202002308
